Adgenix will be an exclusive distributor of Premaitha Health-s DNA prenatal screeneing test Iona, in France.
Premaitha Health said Wednesday that Adgenix has already signed up its first laboratory customer for Premaitha in France, with a signed contract for a minimum of three years to supply LaboSud with the Iona test. Premaitha noted that there are about 820,000 births in France every year.
As for LaboSud, Premaitha explained it was a private group of reference laboratories in the Montpellier region of France. It provides medical and diagnostic laboratory services to clinics and hospitals from the Languedoc-Roussillon region with plans to expand its offering to all of France.
The Iona test estimates the risk of a fetus being affected by Down’s syndrome and other serious genetic conditions by analyzing cell-free fetal DNA from a sample of maternal blood, known as non-invasive prenatal testing (NIPT).
Dr Stephen Little, CEO of Premaitha said: “Securing our first French partnership with LaboSud and Adgenix is an important step forward for us as we continue to expand the reach of the Iona test across Europe. Our NIPT test provides more accurate and faster results that will benefit more pregnant women in France.
“We look forward to getting the Iona test up and running at LaboSud with our world class technical support team and training programme. The support of Adgenix as our local distributor has also been a huge benefit in establishing this customer and we hope to continue to develop this and other relationships.”